Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Early research (Phase 1)Looking for participantsNCT05542407What this trial is testingONC201 and Atezolizumab in Obesity-Driven Endometrial CancerWho this might be right forEndometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Ended earlyNCT00447226What this trial is testingRandomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy ExistsWho this might be right forCancer GlaxoSmithKline 32
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Large-scale testing (Phase 3)Study completedNCT00006027What this trial is testingComparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial CancerWho this might be right forEndometrial Cancer Radiation Therapy Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002493What this trial is testingRadiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerPsychosocial Effects of Cancer and Its Treatment Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00025467What this trial is testingThalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more National Cancer Institute (NCI) 60
Not applicableUnknownNCT01150682What this trial is testingRole of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial CancerWho this might be right forEndometrial Cancer Gynecologic Oncology Group 865
Testing effectiveness (Phase 2)Study completedNCT04080284What this trial is testingTrial of Maintenance With Niraparib- Uterine Serous CarcinomaWho this might be right forEndometrial CancerPapillary Serous Endometrial CarcinomaUterine Serous Carcinoma+2 more Northwell Health 22
Testing effectiveness (Phase 2)Study completedNCT00515073What this trial is testingPapillary Serous Carcinoma of the EndometriumWho this might be right forEndometrial Cancer M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Early research (Phase 1)Active Not RecruitingNCT02208375What this trial is testingMTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianWho this might be right forBRCA1 Mutation CarrierBRCA2 Mutation CarrierEndometrial Adenocarcinoma+13 more M.D. Anderson Cancer Center 159
Testing effectiveness (Phase 2)Study completedNCT04719273What this trial is testingOnapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial CancerWho this might be right forRefractory Endometrial AdenocarcinomaRefractory Endometrial CarcinomaRefractory Endometrial Clear Cell Adenocarcinoma+4 more Thomas Jefferson University 14
Large-scale testing (Phase 3)Study completedNCT01672892What this trial is testingStandard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical CancerWho this might be right forCervical CancerEndometrial CancerGastrointestinal Complications+4 more Radiation Therapy Oncology Group 289
Testing effectiveness (Phase 2)Ended earlyNCT05001282What this trial is testingEvaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more Elucida Oncology 79
Early research (Phase 1)UnknownNCT05498597What this trial is testingAMT-151 in Patients With Selected Advanced Solid TumoursWho this might be right forAdvanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more Multitude Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826What this trial is testingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneWho this might be right forEndometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT03836157What this trial is testingMirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial CancerWho this might be right forEndometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more University of Oklahoma
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757What this trial is testingInvestigate APL-5125 in Adults With Advanced Solid TumorsWho this might be right forColorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more Apollo Therapeutics Ltd 100